Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Metadata
Title
Refractory Thrombocytopenia, an Unusual Myelodysplastic Syndrome with an Initial Presentation Mimicking Idiopathic Thrombocytopenic Purpura
Authors
Jun Qian
Yongquan Xue
Jinlan Pan
Jiannong Cen
Wei Wang
Zixing Chen
Publication date
01-02-2005
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2005
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.A10412

Other articles of this Issue 2/2005

International Journal of Hematology 2/2005 Go to the issue

OriginalPaper

Helicobacter pylori Infection and Idiopathic Thrombocytopenic Purpura

Case Report

Isolated Hyperkalemia Associated with Cyclosporine Administration in Allogeneic Stem Cell Transplantation for Renal Cell Carcinoma

OriginalPaper

The Effect of Antiplatelet Autoantibodies on Megakaryocytopoiesis

Letter to the Editor

A Flare-Up of Chronic Graft-versus-Host Disease of the Liver That Mimics Acute Hepatitis in a Recipient of an Allogeneic Peripheral Blood Stem Cell Transplant

Review Article

Bone Marrow Transplantation from the Personal Viewpoint

Letter to the Editor

Thromboprophylaxis with Reviparin in a Patient with Acquired Hemophilia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits